Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
9.3%
% of IXJ's 113 holdings also in XDNA
43.5%
% of XDNA's 23 holdings also in IXJ
Overlap by Weight
Sector Drift (IXJ minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 4.1% | 3.8% | 3.8% |
|
THERMO FISHER SCIENTIFIC INC | 3.0% | 9.5% | 3.0% |
 |
NOVARTIS AG | 2.7% | 3.0% | 2.7% |
 |
SANOFI-AVENTIS | 1.4% | 3.2% | 1.4% |
|
BRISTOL-MYERS SQUIBB CO | 1.4% | 1.6% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
IXJ Overweight Relative to XDNA
|
ELI LILLY & CO | 8.1% |
|
UNITEDHEALTH GROUP INC | 6.5% |
 |
NOVO NORDISK A/S-B | 5.6% |
|
JOHNSON & JOHNSON | 4.7% |
|
MERCK & CO. INC. | 4.5% |
 |
ASTRAZENECA PLC | 2.9% |
|
ABBOTT LABORATORIES | 2.6% |
|
ROCHE HOLDING LTD | 2.4% |
|
DANAHER CORP | 2.2% |
|
PFIZER INC | 2.1% |
IXJ Underweight Relative to XDNA
|
CRISPR THERAPEUTICS AG | -15.1% |
|
BEAM THERAPEUTICS, INC. | -13.7% |
|
INTELLIA THERAPEUTICS, INC. | -8.7% |
|
THERMO FISHER SCIENTIFIC INC | -6.6% |
|
PRIME MEDICINE, INC. | -5.9% |
|
EDITAS MEDICINE, INC. | -5.7% |
|
CARIBOU BIOSCIENCES, INC. | -4.7% |
|
VERVE THERAPEUTICS, INC. | -4.5% |
|
POSEIDA THERAPEUTICS, INC. | -4.1% |
|
ALLOGENE THERAPEUTICS, INC. | -3.4% |